The value of adding MRI to a clinical Treat-To-Target strategy in rheumatoid arthritis patients in clinical remission: Clinical and radiographic outcomes from the IMGINE-RA randomized controlled trial

Signe Møller-Bisgaard (Speaker), Hørslev-Petersen, K. (Speaker), Bo Jannik Ejbjerg (Speaker), Merete Lund Hetland (Speaker), Lykke Midtbøll Ørnbjerg (Speaker), Daniel Glinatski (Speaker), J. Møller (Speaker), Michael Boesen (Speaker), R Christensen (Speaker), Kristian Stengaard-Pedersen (Speaker), Ole Rintek Madsen (Speaker), B. Jensen (Speaker), Jan Alexander Villadsen (Speaker), Ellen Margrethe Hauge (Speaker), Philip Bennett (Speaker), Hendricks, O. (Speaker), Karsten Asmussen (Speaker), Marcin Ryszard Kowalski (Speaker), Hanne Lindegaard (Speaker), Mai Nielsen, S. (Speaker), Henning Bliddal (Speaker), N Krogh (Speaker), Ellingsen, T. J. (Speaker), AH Nielsen (Speaker), Lone Balding (Speaker), Anne Grethe Jurik (Speaker), H. Thomsen (Speaker), Mikkel Østergaard (Speaker)